Herpes zoster and the prevention of postherpetic neuralgia: beyond antiviral therapy.
Tenser
Richard B
RB
Dworkin
Robert H
RH
D000588:Amines / Q000627:therapeutic use*; D000701:Analgesics, Opioid / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D015220:Calcium Channels / Q000187:drug effects* / Q000502:physiology; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D024882:Drug Resistance, Viral / Q000502:physiology; D000077206:Gabapentin; D006562:Herpes Zoster / Q000150:complications*; D006801:Humans; D051474:Neuralgia, Postherpetic / Q000235:genetics / Q000517:prevention & control* / Q000821:virology; D055502:Secondary Prevention; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use*
D000588:Amines; D000701:Analgesics, Opioid; D000927:Anticonvulsants; D000998:Antiviral Agents; D015220:Calcium Channels; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin